patient_id	feature_display	tested_subfeature	therapy_name	n_mut	n_wt	n_mut_tested	n_wt_tested	mut_ic50_median	mut_ic50_mean	mut_ic50_std	wt_ic50_median	wt_ic50_mean	wt_ic50_std	pvalue_mww	statistic
MEL-IPI_Pat119	NRAS p.Q61R (Missense)	NRAS	Selumetinib	152	1671	76	652	27.454	88.106	141.237	76.712	184.463	366.615	0.0	31515.0
MEL-IPI_Pat119	NRAS p.Q61R (Missense)	NRAS Somatic Variant	Selumetinib	102	1721	54	674	16.818	64.816	128.408	76.712	183.184	361.712	1.926e-06	25278.0
MEL-IPI_Pat119	NRAS p.Q61R (Missense)	NRAS Somatic Variant Missense	Selumetinib	100	1723	53	675	16.602	60.604	125.814	76.81	183.34	361.466	7.004e-07	25202.0
MEL-IPI_Pat119	NRAS p.Q61R (Missense)	NRAS Somatic Variant Missense p.Q61R	Selumetinib	12	1811	8	720	10.416	50.806	116.781	71.056	175.778	352.633	0.011	4376.0
MEL-IPI_Pat119	EGFR Deletion	EGFR	Gefitinib	242	1581	138	614	18.934	31.922	42.565	27.148	45.733	64.802	0.0	50477.5
MEL-IPI_Pat119	EGFR Deletion	EGFR Copy Number	Gefitinib	139	1684	81	671	20.562	31.526	45.523	26.523	44.607	63.077	0.004	32548.0
MEL-IPI_Pat119	EGFR Deletion	EGFR Copy Number Deletion	Gefitinib	17	1806	9	743	24.096	28.665	19.808	26.016	43.374	61.854	0.9	3425.0
